Understanding the Quality of Earnings Process in PT Practice Acquisitions
A guide for PT practice owners preparing for a sale — what buyers examine in a QoE analysis, why each element matters, and how your financials will be scrutinized before any deal closes.
When a buyer targets a physical therapy practice, their first substantive financial step is commissioning a Quality of Earnings (QoE) analysis. This report — not your tax returns, not your P&L summary, and not your broker's memo — becomes the definitive financial basis on which every element of the transaction is negotiated. Understanding it thoroughly is one of the highest-return investments any PT practice owner can make before going to market.
It Answers One Critical Question
A QoE report asks: Is the earnings figure the seller presents an accurate, sustainable, and recurring representation of what the business actually produces? The answer shapes valuation multiples, deal structure, escrow requirements, and whether a deal closes at all.
24–36 Months of Deep Financial Data
A typical QoE spans three to six weeks and covers at least 24 to 36 months of financial data: normalized EBITDA, revenue trend by payer, working capital, provider productivity, referral source analysis, and a complete review of accounting policies and estimates.
The Multiplier Effect on Valuation
A buyer paying 5× EBITDA for a practice reporting $1M in earnings is implicitly paying $5M. If the QoE reveals only $750K is sustainable, the price drops to $3.75M — a $1.25 million swing driven entirely by the QoE process. Every dollar of earnings that cannot be defended is a dollar used to negotiate the price down.
Specialists Who've Seen Dozens of PT Practices
The buyer's QoE is performed by a transaction advisory team within a CPA firm, often supplemented by a healthcare consulting firm. Private equity sponsors maintain preferred vendor relationships with firms that specialize in outpatient therapy. These analysts are not generalists — they are acutely attuned to the patterns that correlate with inflated earnings or hidden risk.
In a physical therapy practice acquisition valued at a 5× EBITDA multiple, a single $100,000 reduction in defensible, normalized EBITDA translates to a $500,000 reduction in purchase price. Buyers apply this multiplier ruthlessly to every unsupported add-back, every undisclosed liability, and every component of revenue they cannot verify as sustainable — which is exactly why QoE preparation is the most valuable pre-sale investment a PT owner can make.
How Buyers Deconstruct Your Revenue Stream
Buyers apply a gross-to-net revenue waterfall beginning with total gross charges and working through every reduction: contractual adjustments, secondary adjustments, bad debt write-offs, and other revenue deductions. Each layer is benchmarked against industry norms. A practice whose contractual adjustment rate has deteriorated by more than two to three percentage points over 24 months will face pointed questions about why — and what that trend implies for the future.
Buyers also decompose every dollar by payer type: commercial insurance, Medicare Part B, Medicaid, workers' compensation, motor vehicle accident, self-pay. Each carries a different reimbursement rate, collection cycle, and regulatory risk profile.
Medicare concentration above 40%: Subject to annual CMS rulemaking, periodic congressional intervention, and the Multiple Procedure Payment Reduction (MPPR) policy — all of which can materially affect future revenue without any change in patient volume.
Workers' comp / MVA surge: These categories carry higher reimbursement rates but significant collection volatility. A practice with a 12-month surge in auto or workers' comp may present an artificially elevated revenue base unlikely to persist.
Concentration in a single location: 70%+ of revenue from one clinic faces haircuts tied to concentration risk — especially if anchored to a hospital or physician group relationship that may not survive ownership transition.
36-Month Monthly Revenue Trend: QoE analysts consistently request monthly revenue data spanning at least 36 months. This reveals seasonal patterns, provider departures, payer contract changes, and unusual spikes or troughs. A practice with strong trailing-twelve-month revenue but a material downward inflection in the final six months will have significant difficulty supporting its stated valuation — buyers will project that trend forward, not backward.
The Most Contentious Component of Every PT Practice QoE
• Owner compensation in excess of market-rate replacement cost for a clinical director performing equivalent duties
• Owner personal expenses run through the business — health insurance premiums, automobile expenses, personal travel, club memberships
• One-time legal fees, settlement costs, or regulatory remediation expenses
• Non-recurring facility relocation or build-out costs
• Depreciation and amortization (standard EBITDA adjustment)
• Discretionary profit-sharing or bonus distributions not tied to ongoing operational requirements
• Recurring owner salary classified as a "distribution" or structured below market rate to inflate EBITDA — buyers normalize to market compensation regardless
• Equipment lease payments argued as one-time — if operationally necessary, the buyer will incur equivalent costs going forward
• Marketing or software expenses categorized as non-recurring when they represent normal business development
• Rent paid to an owner-related entity below market rate — buyers normalize to fair market value, which frequently reduces EBITDA rather than increases it
• Staffing agency expenses argued as non-recurring when provider attrition is a persistent pattern
One of the most frequently encountered issues in PT practice transactions: the practice owner also owns the real estate and charges below-market rent. This feels like a benefit — but it destroys negotiating leverage during QoE.
Sellers who own the real estate and charge below-market rent often plan to present this as a "benefit" to the buyer — a favorable lease they're generously passing along. They expect the QoE team to view the business favorably because of lower rent expense.
The seller's accountant may have even included below-market rent as an EBITDA add-back in the offering memorandum, showing what the "market-rate adjusted" EBITDA would be.
The QoE team normalizes rent to the prevailing market rate for equivalent clinical space in the same submarket. If market rent is $28/sq ft annually but the practice pays $18, a 4,000 sq ft clinic carries $40,000 in annual EBITDA that disappears in the normalized calculation.
The same scrutiny applies in reverse. Above-market rent charged by an owner to an owner-affiliated entity will also be examined — buyers treat any non-arm's-length real estate arrangement as a potential hidden liability, regardless of which direction it runs.
Add-backs above 10–15% of reported EBITDA are a red flag in themselves. An unusually high proportion of proposed add-backs signals that the practice's reported earnings are structurally dependent on owner-specific arrangements, making the normalized earnings figure less reliable and more difficult to defend in negotiations.
A Simultaneous Financial and Operational Investigation
Buyers request a detailed AR aging report organized by payer and by days outstanding (0–30, 31–60, 61–90, 91–120, 120+ days). In a well-managed PT practice, the majority of commercial AR should reside in the 0–60 day bucket, with minimal exposure beyond 90 days for commercial claims and no significant exposure beyond 30–45 days for Medicare, which typically adjudicates within 14–21 days of submission.
Accumulation in the 90-day-plus buckets signals: deficient clinical documentation, coding errors, failure to obtain prior authorizations, payer disputes, or inadequate follow-up processes.
Industry best practice for outpatient PT: 30–45 days. A practice with DAR above 50 days has an observable revenue cycle deficiency that buyers will price into the transaction — either through a working capital target adjustment, a post-closing escrow holdback, or a reduction in headline purchase price.
Working Capital Target: Buyers argue for a target based on average normalized working capital over the trailing 12-month period. Deteriorating AR, rising accrued liabilities, or unusual timing around the closing date can all create working capital shortfalls that reduce effective deal proceeds in ways sellers do not always anticipate.
| DAR Range | Buyer Interpretation | Likely Deal Impact |
|---|---|---|
| Under 35 days | Excellent revenue cycle management | Positive signal; no adjustment |
| 35–50 days | Average; consistent with industry | Minor scrutiny; working capital discussion |
| 50–65 days | Below average; systemic issues suspected | Price adjustment or escrow holdback likely |
| Over 65 days | Material revenue cycle deficiency | Significant price reduction; deal risk |
Billing Operations Review: The QoE team will also examine whether billing is handled in-house or by a third party, the credentials of billing staff, the practice management software in use, denial rates by payer, and the appeals process. A practice that relies on a single billing employee nearing retirement, or one that recently transitioned billing platforms with collection disruptions, presents elevated post-closing operational risk that buyers reflect in valuation.
Providers Are the Revenue Engine — Buyers Know It
A practice where a single treating therapist generates more than 35–40% of total clinical visit volume, or where the owner maintains exclusive referral relationships with key physicians, represents a key man risk scenario. Buyers address this through employment agreement requirements, earnout structures, or purchase price reductions.
Sellers who plan to exit clinical practice entirely at closing face the greatest valuation pressure from this dynamic. A practice owner who has cultivated 30 years of physician relationships in a community cannot simply hand those relationships to a new owner at the closing table. Buyers understand this — and they structure valuations accordingly.
Revenue per FTE and visits per FTE: Benchmarked against published industry data and the buyer's own portfolio. Productivity materially below benchmarks raises questions about underutilized capacity, below-average reimbursement, or scheduling inefficiencies. Unusually high revenue per visit may signal aggressive billing practices subject to compliance review.
Compensation as % of revenue: Provider compensation — base salary, productivity bonuses, benefits, payroll taxes — typically represents 55% to 70% of net revenue. Below-market provider compensation signals retention risk post-close; above-market may indicate near-term margin improvement opportunity.
Staff turnover: High therapist turnover generates compounding costs — recruiting, temporary staffing, onboarding, and the inevitable volume dip accompanying a new hire's ramp-up. A practice that has filled the same position three times in 24 months carries a documented instability pattern buyers will price appropriately. Typically, turnover exceeding 25% annually is considered a hard red flag and will be called out explicitly in the QoE findings.
Preparation Strategy: Practice owners who are personally maintaining key physician referral relationships should invest in clinical marketing, care coordination initiatives, and institutional relationship development in the 24 months before a sale. Every new referring physician relationship developed during this period represents a quantifiable reduction in key man risk — and a corresponding improvement in the sustainability narrative.
The Referral Pipeline Is the Future Revenue Pipeline
Buyers request a detailed referral source report covering at least 24 months, identifying every physician, physician group, urgent care, employer, or self-referral source. A practice where the top three referring physicians account for more than 50% of total visits faces material concentration risk.
The departure of a single key referral source — due to retirement, relocation, competitive recruitment by a health system, or a change in hospital affiliation — could trigger a sudden, significant decline in patient volume that the new owner inherits without recourse.
Sophisticated buyers analyze new patient intake rates — the number of new patients beginning episodes of care each month. A declining new patient rate, even in a period of stable total visit volume, signals a deterioration in the referral pipeline that will manifest as volume decline as existing patients complete treatment and are not replaced.
Practices that have extended average episode length to compensate for declining new patient intake may be masking a referral pipeline problem behind apparent volume stability that is temporary and unsustainable. Buyers are specifically trained to identify this pattern.
The Relationship Ownership Question: Equally important to referral concentration is whether key referral relationships are professional and institutional in nature — based on care quality, outcomes data, and communication — or whether they are personal relationships held exclusively by the owner or a departing provider. Referral relationships that cannot be transferred with the business represent intangible asset erosion that directly reduces enterprise value.
The Reimbursement Landscape Is One of the Most Complex in Ambulatory Care
For each commercial payer, the QoE team requests the full executed contract and applicable fee schedules, amendments, or rate letters. Discrepancies between billed rates and contracted rates are a common source of revenue leakage buyers identify and price into working capital expectations.
A contract with a major commercial payer expiring within 12–18 months of anticipated closing introduces renegotiation risk that the new owner will inherit. Buyers examine whether any contracts are approaching their expiration date or automatic renewal window.
Practices with high Medicare concentration will be stress-tested under hypothetical scenarios involving rate reductions of 5%, 10%, and 15% to assess EBITDA resilience. These sensitivity analyses directly inform both the buyer's bid price and their required returns on the transaction.
Value-based and managed care arrangements — bundled payment models, ACO relationships, capitated managed care contracts — require specialized analysis during QoE. Buyers examine risk-sharing provisions, quality metric requirements, and termination clauses to determine whether they represent a revenue enhancement or a concealed financial liability.
Medicare Physician Fee Schedule Risk: Medicare Part B outpatient therapy is updated annually and subject to significant policy changes that directly affect reimbursement rates. The practice has no ability to negotiate Medicare rates — making Medicare concentration a one-sided, uncontrollable reimbursement risk that sophisticated buyers model conservatively and price accordingly.
Liabilities That Don't Appear on the Balance Sheet — But Are Very Real
One of the most consequential categories of hidden liability is the potential for Medicare or Medicaid overpayment exposure. Government payers conduct post-payment audits — including Targeted Probe and Educate (TPE) reviews, CERT reviews, and RAC audits — that can result in demands for repayment covering multiple prior years.
A practice that has undergone an audit, received a letter from a Recovery Audit Contractor, or experienced an unusually high denial rate from Medicare without a corresponding internal review is carrying potential overpayment exposure that may not be reflected anywhere in its financial statements.
Malpractice tail coverage: For asset purchases — the most common structure in PT M&A — the seller typically retains responsibility for claims arising from pre-closing acts. Tail coverage cost is a negotiated item that can represent a meaningful transaction cost.
Contractor misclassification: Practices that utilize independent contractors face scrutiny regarding proper classification under IRS guidelines. Misclassification carries exposure for unpaid payroll taxes, FLSA back-wage liability, and state wage-and-hour penalties.
Lease obligations: In an asset purchase, the buyer must assume or renegotiate all facility leases. Long-term commitments at above-market rates, restrictive assignment provisions, or personal guarantees the owner provided on clinic leases can all affect deal structure and net proceeds.
Disclosure Is Always Better Than Discovery: Any financial obligation, related-party arrangement, or liability not clearly reflected in the financial statements provided to the buyer — whether by accounting presentation, oversight, or omission — constitutes a material misrepresentation with potential legal consequences. It will, at minimum, result in significant deal renegotiation. Proactive disclosure protects leverage and preserves trust.
Revenue Concentration in a Single Payer >40%
Payer concentration creates acute sensitivity to one contract renegotiation, rate reduction, or termination.
Undisclosed or Ongoing Government Audits
Any Medicare/Medicaid audit not voluntarily disclosed prior to the QoE creates immediate deal uncertainty and triggers indemnification negotiations.
Owner-Treating Therapist with No Clinical Succession Plan
When the selling owner is the practice's highest-volume clinician with no successor referral relationships developed, buyers face unquantifiable revenue risk.
Days in AR Above 65 with Significant 90+ Day Balances
DAR above 50 triggers pricing scrutiny; above 65 constitutes a material revenue cycle deficiency. Elevated AR aging signals both a current collection problem and a need for operational and capital investment post-close.
Add-Backs Exceeding 10–15% of Reported EBITDA
A practice this reliant on owner-specific add-backs produces a normalized earnings figure that is less reliable and harder to defend in buyer negotiations.
Material Revenue Decline in Trailing Six Months
A downward inflection in monthly revenue — even if trailing-twelve-month figures appear stable — suggests a deteriorating referral pipeline or operational problem buyers will price conservatively.
High Provider Turnover Exceeding 25% Annually
Elevated turnover carries direct financial costs and indirect revenue risk through disruption of patient care continuity and referral relationships.
Referral Concentration of >50% in 3 or Fewer Physicians
A referral base where three or fewer physicians drive more than half of total visits — and those relationships are personal rather than institutional — represents a fragile revenue foundation whose stability cannot be contractually guaranteed.
Billing Managed by a Single, Uncredentialed Internal Employee
Revenue cycle management by a single long-tenured employee with no formal credentials, on legacy software, with no management oversight or performance benchmarking.
Single-Location Revenue Concentration ≥70% or Undisclosed Off-Balance-Sheet Liabilities
A practice where one clinic generates 70%+ of revenue — especially where the anchor relationship cannot be contractually transferred to the new owner — or where related-party arrangements are not clearly reflected in financial statements constitutes a material misrepresentation that will, at minimum, result in significant deal renegotiation.
The Best Time to Prepare for QoE Is Before the Buyer's Accountants Walk In
The practices that achieve the best outcomes in M&A transactions are not the ones that prepared the best pitch deck. They are the ones that built the kind of business that doesn't need one — because the financial record speaks for itself. Mihama works with PT practice owners — often 12 to 24 months before a planned sale — to identify QoE vulnerabilities, improve revenue cycle metrics, diversify referral bases, and position your practice to withstand the most rigorous buyer due diligence review. Every operational improvement made today translates directly into a higher, more defensible, and more certain transaction value when the time comes.
347-878-2941
Confidential consultation, no retainer required
[email protected]
We respond within one business day
www.mihamainc.com
Resources, case studies & transaction experience